Nanotechnology Now |
Home > Press > Arrowhead Research to Present at 2012 Wedbush PacGrow Life Sciences Management Access Conference
 |
Abstract:
Arrowhead Research Corporation (NASDAQ: ARWR), a targeted therapeutics company, today announced that its President and Chief Executive Officer, Dr. Chris Anzalone, will present a company overview at the 2012 Wedbush PacGrow Life Sciences Management Access Conference on Tuesday, August 14th at 4:15 pm Eastern time at Le Parker Meridien Hotel in New York City.
Arrowhead Research to Present at 2012 Wedbush PacGrow Life Sciences Management Access Conference
Pasadena, CA | Posted on August 9th, 2012A live webcast of the presentation can be accessed by visiting the News & Events section of the company's website, www.arrowheadresearch.com/presentations. A replay will also be archived on the website and available for 60 days.
####
About Arrowhead Research Corporation
Arrowhead Research Corporation is a clinical stage targeted therapeutics company with development programs in oncology, obesity, and infectious disease. The company is leveraging its platform technologies to design and develop peptide-drug conjugates (PDCs) that specifically home to cell types of interest while sparing off-target tissues, create targeted drugs based on the gene silencing RNA interference (RNAi) mechanism, and work with partners to create improved versions of traditional small molecule drugs.
For more information please visit www.arrowheadresearch.com, or follow us on Twitter @ArrowRes. To be added to the Company's email list to receive news directly, please send an email to
For more information, please click here
Contacts:
Investor Relations Contact:
Michael Levitan
The Trout Group, LLC
646-378-2920
Copyright © Arrowhead Research Corporation
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Bookmark:
| Related News Press |
News and information
Sound waves precisely position nanowires June 19th, 2013
Scientists Use Nanotechnology to Increase Thermal Stability of Essential Oils June 19th, 2013
Production of Bioactive Material for Quick Treatment of Bone Damages June 19th, 2013
Investments/IPO's/Splits
Dr. Ben J. Lipps designated as Chairman of the Management Board and Chief Executive Officer of Nanostart-holding MagForce AG June 17th, 2013
Harris & Harris Group Notes Carl Zeiss' Planned Acquisition of Xradia June 13th, 2013
Nanomedicine
Production of Bioactive Material for Quick Treatment of Bone Damages June 19th, 2013
3-D printing could lead to tiny medical implants, electronics, robots, more June 18th, 2013
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
Announcements
Sound waves precisely position nanowires June 19th, 2013
Scientists Use Nanotechnology to Increase Thermal Stability of Essential Oils June 19th, 2013
Production of Bioactive Material for Quick Treatment of Bone Damages June 19th, 2013
Events/Classes
Research and industry frontrunners gather in Dublin at the EuroNanoForum, Europe’s largest nanotechnology conference June 18th, 2013
Discover the ‘Nanostructure Advantage’ at ECerS 2013, Booth 5: Innovnano presents nanostructured powders for high performance ceramics June 17th, 2013
SEMATECH to Address Critical Supply Chain Challenges and Present Latest Technology Advances at SEMICON West 2013 June 17th, 2013
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
University Technology Transfer & Patents
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||
abbigliamento uomo
Computer Accessories
| © Copyright 1999-2013 7th Wave, Inc. All Rights Reserved | PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE |